Exelon (NASDAQ:EXC – Get Rating) had its price objective raised by BMO Capital Markets from $49.00 to $51.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. BMO Capital Markets’ price objective points to a potential upside of 13.92% from the company’s current price.
A number of other equities analysts also recently issued reports on the stock. Wells Fargo & Company decreased their price target on shares of Exelon from $52.00 to $49.00 and set an “equal weight” rating for the company in a research note on Thursday. Barclays reduced their price target on shares of Exelon from $50.00 to $46.00 and set an “equal weight” rating for the company in a research report on Monday, July 18th. KeyCorp reduced their price target on shares of Exelon from $53.00 to $45.00 and set an “overweight” rating for the company in a research report on Tuesday, July 19th. JPMorgan Chase & Co. upgraded shares of Exelon from a “neutral” rating to an “overweight” rating and raised their target price for the stock from $47.00 to $55.00 in a report on Wednesday, April 20th. Finally, Morgan Stanley dropped their target price on shares of Exelon from $54.00 to $52.00 and set an “overweight” rating on the stock in a report on Monday, May 23rd. Six analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $48.15.
Exelon Price Performance
EXC stock opened at $44.77 on Thursday. Exelon has a 1 year low of $33.64 and a 1 year high of $50.71. The company has a market cap of $43.88 billion, a P/E ratio of 16.52, a PEG ratio of 2.74 and a beta of 0.57. The firm has a 50-day moving average of $44.83 and a 200 day moving average of $46.14. The company has a debt-to-equity ratio of 1.53, a current ratio of 0.91 and a quick ratio of 0.88.
Insider Buying and Selling
In related news, CEO John Tyler Anthony sold 4,451 shares of Exelon stock in a transaction dated Wednesday, May 18th. The shares were sold at an average price of $47.49, for a total transaction of $211,377.99. Following the completion of the transaction, the chief executive officer now directly owns 974 shares of the company’s stock, valued at approximately $46,255.26. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.19% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Exelon
Several large investors have recently added to or reduced their stakes in EXC. CWM LLC purchased a new stake in Exelon in the 4th quarter valued at about $863,000. Centaurus Financial Inc. lifted its position in shares of Exelon by 38.1% in the 4th quarter. Centaurus Financial Inc. now owns 3,479 shares of the company’s stock worth $201,000 after purchasing an additional 959 shares during the period. Quadrant Capital Group LLC lifted its position in shares of Exelon by 5.2% in the 4th quarter. Quadrant Capital Group LLC now owns 3,547 shares of the company’s stock worth $205,000 after purchasing an additional 175 shares during the period. TIAA FSB lifted its position in shares of Exelon by 2.8% in the 4th quarter. TIAA FSB now owns 38,438 shares of the company’s stock worth $2,215,000 after purchasing an additional 1,030 shares during the period. Finally, Pallas Capital Advisors LLC purchased a new stake in shares of Exelon in the 4th quarter worth approximately $355,000. 80.35% of the stock is owned by hedge funds and other institutional investors.
Exelon Corporation, a utility services holding company, engages in the energy generation, delivery, and marketing businesses in the United States and Canada. It owns nuclear, fossil, wind, hydroelectric, biomass, and solar generating facilities. The company also sells electricity to wholesale and retail customers; and sells natural gas, renewable energy, and other energy-related products and services.
- Get a free copy of the StockNews.com research report on Exelon (EXC)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.